Thoracic Guidelines
This article explores the complexities of determining resectability in patients with non-small cell lung cancer (NSCLC). The authors emphasize that resectability, crucial for deciding treatment pathways, is best assessed by a multidisciplinary tumor board but...
This article explores the complexities of determining resectability in patients with non-small cell lung cancer (NSCLC). The authors emphasize that resectability, crucial for deciding treatment pathways, is best assessed by...
A condensed, granular and yet comprehensive discussion on a small retrospective series on mostly non-iatrogenic trauma of the subclavian and axillary arteries treated mostly by stenting. Professor Veller’s viewpoint is...
The value for the surgical team is to be found in the systematic approach and especially the candid discussion on benefits of pulmonary transplantation, with the frank statement that may...
Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis,...
The highly respected Cochrane Collaboration is in crisis today at its 25th annual meeting in Edinburgh as one board member is expelled and six more resign. There are more links...
Enhanced recovery programs are very popular now, but their benefits have been mostly theoretical. This article describes challenges and outcomes after initiation of such a program, citing decreased costs, lower...
The fourth (re- )classification of cardiopericardial tumours came from the World Health Organisation last year, 11 years after the third. In particular, the malignant fibrous histiocytomas are re classified as...
The paper presents the guidelines for authors on statistical and data reporting for the European Journal of Cardio-Thoracic Surgery (EJCTS) and the Interactive CardioVascular and Thoracic Surgery (ICVTS). It...
The British Thoracic Society developed guidelines for evaluation and management of solitary pulmonary nodules based on a literature review and expert opinion. New features include the use of a malignancy...
CMS determined that the evidence of benefit for CT screening for lung cancer is sufficient to permit this as an annual benefit for Medicare and Medicaid recipients in the US....
The authors examined cost-effectiveness in the National Lung Screening Trial (NLST), examining incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs) associated with low dose CT screening. The ICER was...
2014 consensus guidelines on the perioperative evaluation and management of patients undergoing NONCARDIAC surgery.
...

